STOCK MARKET BSE NSE

First indigenous COVID-19 vaccine candidate developed by Zydus to enter human trials

Published: 16th July 2020 07:25 PM  |   Last Updated: 16th July 2020 07:26 PM  

The Department of Biotechnology under the Union Ministry of Science and Technology has announced that ZyCoV-D, the plasmid DNA vaccine candidate designed and developed by Zydus, has entered Phase I/II clinical trials. This makes it the first indigenously developed vaccine candidate for COVID-19 to be administered to humans in India.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now
TAGS
Covid 19

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp